The Scientist

» preclinical

Most Recent

Mice receiving the treatment produced their own monoclonal antibodies and survived infection with the life-threatening pathogen Pseudomonas aeruginosa.

2 Comments

Neurons derived from human induced pluripotent stem cells fill in for lost dopamine neurons in a primate model of the disease.

0 Comments

Researchers overestimate the reliability of findings from animal studies that are part of the Reproducibility Project: Cancer Biology.

0 Comments

Animal experiments published in a handful of cardiovascular journals mostly ignore NIH guidelines.

2 Comments

Scientists shut down cancer-causing fusion genes with CRISPR.

5 Comments

At the annual American Association for Cancer Research meeting, researchers discuss the importance of understanding the epigenetic contributors to cancer progression and treatment response.

0 Comments

image: Rethinking a Cancer Drug Target

Rethinking a Cancer Drug Target

By | March 26, 2017

The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

0 Comments

image: RNA Vaccine for Zika Shows Promise

RNA Vaccine for Zika Shows Promise

By | February 2, 2017

Researchers use modified messenger RNA to produce a vaccine that protected mice and nonhuman primates from infection.

1 Comment

image: The Trouble With Sex in Science

The Trouble With Sex in Science

By | August 9, 2016

Researchers argue for the consideration of hormones and sex chromosomes in preclinical experiments.

0 Comments

image: TS Picks: February 11, 2016

TS Picks: February 11, 2016

By | February 11, 2016

Reproducibility edition

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. German Scientists Resign from Elsevier Journals’ Editorial Boards
  3. Symmetrical Eyes Indicate Dyslexia
  4. Judge Recommends Ruling to Block Internet Access to Sci-Hub
RayBiotech